nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—CYP3A4—Tamoxifen—pancreatic cancer	0.0468	0.24	CbGbCtD
Desvenlafaxine—CYP3A4—Erlotinib—pancreatic cancer	0.0398	0.204	CbGbCtD
Desvenlafaxine—CYP3A4—Irinotecan—pancreatic cancer	0.036	0.185	CbGbCtD
Desvenlafaxine—CYP3A4—Docetaxel—pancreatic cancer	0.0264	0.135	CbGbCtD
Desvenlafaxine—CYP3A4—Sunitinib—pancreatic cancer	0.0262	0.135	CbGbCtD
Desvenlafaxine—CYP3A4—Doxorubicin—pancreatic cancer	0.0196	0.101	CbGbCtD
Desvenlafaxine—Myocardial infarction—Docetaxel—pancreatic cancer	0.00181	0.00225	CcSEcCtD
Desvenlafaxine—Hypertension—Irinotecan—pancreatic cancer	0.00181	0.00224	CcSEcCtD
Desvenlafaxine—Decreased appetite—Sunitinib—pancreatic cancer	0.0018	0.00224	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00179	0.00222	CcSEcCtD
Desvenlafaxine—Fatigue—Sunitinib—pancreatic cancer	0.00179	0.00222	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00178	0.00221	CcSEcCtD
Desvenlafaxine—Constipation—Sunitinib—pancreatic cancer	0.00177	0.0022	CcSEcCtD
Desvenlafaxine—Hypertension—Gemcitabine—pancreatic cancer	0.00176	0.00218	CcSEcCtD
Desvenlafaxine—Epistaxis—Docetaxel—pancreatic cancer	0.00174	0.00217	CcSEcCtD
Desvenlafaxine—Asthenia—Tamoxifen—pancreatic cancer	0.00174	0.00216	CcSEcCtD
Desvenlafaxine—Convulsion—Fluorouracil—pancreatic cancer	0.00174	0.00216	CcSEcCtD
Desvenlafaxine—Hot flush—Epirubicin—pancreatic cancer	0.00173	0.00215	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00172	0.00214	CcSEcCtD
Desvenlafaxine—Asthenia—Erlotinib—pancreatic cancer	0.00172	0.00213	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Epirubicin—pancreatic cancer	0.00172	0.00213	CcSEcCtD
Desvenlafaxine—Shock—Irinotecan—pancreatic cancer	0.00168	0.00209	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Irinotecan—pancreatic cancer	0.00167	0.00208	CcSEcCtD
Desvenlafaxine—Diarrhoea—Tamoxifen—pancreatic cancer	0.00166	0.00206	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00165	0.00205	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Docetaxel—pancreatic cancer	0.00164	0.00204	CcSEcCtD
Desvenlafaxine—Diarrhoea—Erlotinib—pancreatic cancer	0.00164	0.00203	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Docetaxel—pancreatic cancer	0.00163	0.00203	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00163	0.00202	CcSEcCtD
Desvenlafaxine—Urethral disorder—Docetaxel—pancreatic cancer	0.00163	0.00202	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Epirubicin—pancreatic cancer	0.00163	0.00202	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.00162	0.00201	CcSEcCtD
Desvenlafaxine—Skin disorder—Gemcitabine—pancreatic cancer	0.00161	0.00201	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00161	0.002	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Fluorouracil—pancreatic cancer	0.0016	0.00199	CcSEcCtD
Desvenlafaxine—Hot flush—Doxorubicin—pancreatic cancer	0.0016	0.00199	CcSEcCtD
Desvenlafaxine—Dizziness—Tamoxifen—pancreatic cancer	0.0016	0.00199	CcSEcCtD
Desvenlafaxine—Tachycardia—Fluorouracil—pancreatic cancer	0.0016	0.00198	CcSEcCtD
Desvenlafaxine—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.00159	0.00197	CcSEcCtD
Desvenlafaxine—Dizziness—Erlotinib—pancreatic cancer	0.00158	0.00197	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Docetaxel—pancreatic cancer	0.00157	0.00195	CcSEcCtD
Desvenlafaxine—Eye disorder—Docetaxel—pancreatic cancer	0.00155	0.00193	CcSEcCtD
Desvenlafaxine—Insomnia—Irinotecan—pancreatic cancer	0.00154	0.00192	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Docetaxel—pancreatic cancer	0.00154	0.00191	CcSEcCtD
Desvenlafaxine—Vomiting—Tamoxifen—pancreatic cancer	0.00154	0.00191	CcSEcCtD
Desvenlafaxine—Paraesthesia—Irinotecan—pancreatic cancer	0.00153	0.0019	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Sunitinib—pancreatic cancer	0.00153	0.0019	CcSEcCtD
Desvenlafaxine—Rash—Tamoxifen—pancreatic cancer	0.00153	0.00189	CcSEcCtD
Desvenlafaxine—Dermatitis—Tamoxifen—pancreatic cancer	0.00152	0.00189	CcSEcCtD
Desvenlafaxine—Vomiting—Erlotinib—pancreatic cancer	0.00152	0.00189	CcSEcCtD
Desvenlafaxine—Somnolence—Irinotecan—pancreatic cancer	0.00152	0.00188	CcSEcCtD
Desvenlafaxine—Headache—Tamoxifen—pancreatic cancer	0.00152	0.00188	CcSEcCtD
Desvenlafaxine—Rash—Erlotinib—pancreatic cancer	0.00151	0.00187	CcSEcCtD
Desvenlafaxine—Dermatitis—Erlotinib—pancreatic cancer	0.00151	0.00187	CcSEcCtD
Desvenlafaxine—Angiopathy—Docetaxel—pancreatic cancer	0.00151	0.00187	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Doxorubicin—pancreatic cancer	0.0015	0.00187	CcSEcCtD
Desvenlafaxine—Insomnia—Gemcitabine—pancreatic cancer	0.0015	0.00187	CcSEcCtD
Desvenlafaxine—Immune system disorder—Docetaxel—pancreatic cancer	0.0015	0.00186	CcSEcCtD
Desvenlafaxine—Headache—Erlotinib—pancreatic cancer	0.0015	0.00186	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.0015	0.00186	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Docetaxel—pancreatic cancer	0.0015	0.00186	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Epirubicin—pancreatic cancer	0.00149	0.00186	CcSEcCtD
Desvenlafaxine—Paraesthesia—Gemcitabine—pancreatic cancer	0.00149	0.00185	CcSEcCtD
Desvenlafaxine—Chills—Docetaxel—pancreatic cancer	0.00149	0.00185	CcSEcCtD
Desvenlafaxine—Asthenia—Sunitinib—pancreatic cancer	0.00149	0.00185	CcSEcCtD
Desvenlafaxine—Decreased appetite—Irinotecan—pancreatic cancer	0.00148	0.00184	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.00148	0.00184	CcSEcCtD
Desvenlafaxine—Insomnia—Fluorouracil—pancreatic cancer	0.00148	0.00184	CcSEcCtD
Desvenlafaxine—Somnolence—Gemcitabine—pancreatic cancer	0.00148	0.00184	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00147	0.00183	CcSEcCtD
Desvenlafaxine—Fatigue—Irinotecan—pancreatic cancer	0.00147	0.00183	CcSEcCtD
Desvenlafaxine—Paraesthesia—Fluorouracil—pancreatic cancer	0.00147	0.00182	CcSEcCtD
Desvenlafaxine—Alopecia—Docetaxel—pancreatic cancer	0.00147	0.00182	CcSEcCtD
Desvenlafaxine—Breast disorder—Epirubicin—pancreatic cancer	0.00146	0.00182	CcSEcCtD
Desvenlafaxine—Constipation—Irinotecan—pancreatic cancer	0.00146	0.00181	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.00146	0.00181	CcSEcCtD
Desvenlafaxine—Mental disorder—Docetaxel—pancreatic cancer	0.00145	0.00181	CcSEcCtD
Desvenlafaxine—Somnolence—Fluorouracil—pancreatic cancer	0.00145	0.0018	CcSEcCtD
Desvenlafaxine—Malnutrition—Docetaxel—pancreatic cancer	0.00145	0.0018	CcSEcCtD
Desvenlafaxine—Decreased appetite—Gemcitabine—pancreatic cancer	0.00145	0.00179	CcSEcCtD
Desvenlafaxine—Nausea—Tamoxifen—pancreatic cancer	0.00144	0.00178	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00144	0.00178	CcSEcCtD
Desvenlafaxine—Fatigue—Gemcitabine—pancreatic cancer	0.00143	0.00178	CcSEcCtD
Desvenlafaxine—Constipation—Gemcitabine—pancreatic cancer	0.00142	0.00177	CcSEcCtD
Desvenlafaxine—Nausea—Erlotinib—pancreatic cancer	0.00142	0.00177	CcSEcCtD
Desvenlafaxine—Decreased appetite—Fluorouracil—pancreatic cancer	0.00142	0.00176	CcSEcCtD
Desvenlafaxine—Diarrhoea—Sunitinib—pancreatic cancer	0.00142	0.00176	CcSEcCtD
Desvenlafaxine—Dysgeusia—Docetaxel—pancreatic cancer	0.00142	0.00176	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00141	0.00175	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.00138	0.00172	CcSEcCtD
Desvenlafaxine—Dizziness—Sunitinib—pancreatic cancer	0.00137	0.0017	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.00137	0.0017	CcSEcCtD
Desvenlafaxine—Breast disorder—Doxorubicin—pancreatic cancer	0.00135	0.00168	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.00135	0.00168	CcSEcCtD
Desvenlafaxine—Vomiting—Sunitinib—pancreatic cancer	0.00132	0.00164	CcSEcCtD
Desvenlafaxine—Rash—Sunitinib—pancreatic cancer	0.00131	0.00162	CcSEcCtD
Desvenlafaxine—Dermatitis—Sunitinib—pancreatic cancer	0.00131	0.00162	CcSEcCtD
Desvenlafaxine—Headache—Sunitinib—pancreatic cancer	0.0013	0.00161	CcSEcCtD
Desvenlafaxine—Syncope—Docetaxel—pancreatic cancer	0.0013	0.00161	CcSEcCtD
Desvenlafaxine—Palpitations—Docetaxel—pancreatic cancer	0.00128	0.00159	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.00128	0.00159	CcSEcCtD
Desvenlafaxine—Weight increased—Epirubicin—pancreatic cancer	0.00127	0.00158	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Docetaxel—pancreatic cancer	0.00127	0.00158	CcSEcCtD
Desvenlafaxine—Weight decreased—Epirubicin—pancreatic cancer	0.00127	0.00157	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Irinotecan—pancreatic cancer	0.00126	0.00156	CcSEcCtD
Desvenlafaxine—Convulsion—Docetaxel—pancreatic cancer	0.00125	0.00156	CcSEcCtD
Desvenlafaxine—Hypertension—Docetaxel—pancreatic cancer	0.00125	0.00155	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00124	0.00154	CcSEcCtD
Desvenlafaxine—Nausea—Sunitinib—pancreatic cancer	0.00123	0.00153	CcSEcCtD
Desvenlafaxine—Asthenia—Irinotecan—pancreatic cancer	0.00122	0.00152	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00122	0.00152	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.0012	0.0015	CcSEcCtD
Desvenlafaxine—Dry mouth—Docetaxel—pancreatic cancer	0.0012	0.00149	CcSEcCtD
Desvenlafaxine—Asthenia—Gemcitabine—pancreatic cancer	0.00119	0.00148	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00118	0.00147	CcSEcCtD
Desvenlafaxine—Weight increased—Doxorubicin—pancreatic cancer	0.00118	0.00146	CcSEcCtD
Desvenlafaxine—Epistaxis—Epirubicin—pancreatic cancer	0.00118	0.00146	CcSEcCtD
Desvenlafaxine—Weight decreased—Doxorubicin—pancreatic cancer	0.00117	0.00145	CcSEcCtD
Desvenlafaxine—Diarrhoea—Irinotecan—pancreatic cancer	0.00117	0.00145	CcSEcCtD
Desvenlafaxine—Shock—Docetaxel—pancreatic cancer	0.00116	0.00144	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Docetaxel—pancreatic cancer	0.00116	0.00144	CcSEcCtD
Desvenlafaxine—Tachycardia—Docetaxel—pancreatic cancer	0.00115	0.00143	CcSEcCtD
Desvenlafaxine—Skin disorder—Docetaxel—pancreatic cancer	0.00115	0.00142	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00114	0.00142	CcSEcCtD
Desvenlafaxine—Diarrhoea—Gemcitabine—pancreatic cancer	0.00114	0.00141	CcSEcCtD
Desvenlafaxine—Dizziness—Irinotecan—pancreatic cancer	0.00113	0.0014	CcSEcCtD
Desvenlafaxine—Diarrhoea—Fluorouracil—pancreatic cancer	0.00112	0.00139	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.00111	0.00137	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Epirubicin—pancreatic cancer	0.0011	0.00137	CcSEcCtD
Desvenlafaxine—Urethral disorder—Epirubicin—pancreatic cancer	0.0011	0.00136	CcSEcCtD
Desvenlafaxine—Epistaxis—Doxorubicin—pancreatic cancer	0.00109	0.00135	CcSEcCtD
Desvenlafaxine—Vomiting—Irinotecan—pancreatic cancer	0.00109	0.00135	CcSEcCtD
Desvenlafaxine—Dizziness—Fluorouracil—pancreatic cancer	0.00108	0.00134	CcSEcCtD
Desvenlafaxine—Rash—Irinotecan—pancreatic cancer	0.00108	0.00134	CcSEcCtD
Desvenlafaxine—Dermatitis—Irinotecan—pancreatic cancer	0.00108	0.00134	CcSEcCtD
Desvenlafaxine—Headache—Irinotecan—pancreatic cancer	0.00107	0.00133	CcSEcCtD
Desvenlafaxine—Insomnia—Docetaxel—pancreatic cancer	0.00107	0.00133	CcSEcCtD
Desvenlafaxine—Paraesthesia—Docetaxel—pancreatic cancer	0.00106	0.00132	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Epirubicin—pancreatic cancer	0.00106	0.00132	CcSEcCtD
Desvenlafaxine—Vomiting—Gemcitabine—pancreatic cancer	0.00106	0.00131	CcSEcCtD
Desvenlafaxine—Somnolence—Docetaxel—pancreatic cancer	0.00105	0.0013	CcSEcCtD
Desvenlafaxine—Rash—Gemcitabine—pancreatic cancer	0.00105	0.0013	CcSEcCtD
Desvenlafaxine—Dermatitis—Gemcitabine—pancreatic cancer	0.00105	0.0013	CcSEcCtD
Desvenlafaxine—Eye disorder—Epirubicin—pancreatic cancer	0.00105	0.0013	CcSEcCtD
Desvenlafaxine—Tinnitus—Epirubicin—pancreatic cancer	0.00104	0.0013	CcSEcCtD
Desvenlafaxine—Headache—Gemcitabine—pancreatic cancer	0.00104	0.00129	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Epirubicin—pancreatic cancer	0.00104	0.00129	CcSEcCtD
Desvenlafaxine—Vomiting—Fluorouracil—pancreatic cancer	0.00104	0.00129	CcSEcCtD
Desvenlafaxine—Rash—Fluorouracil—pancreatic cancer	0.00103	0.00128	CcSEcCtD
Desvenlafaxine—Dermatitis—Fluorouracil—pancreatic cancer	0.00103	0.00128	CcSEcCtD
Desvenlafaxine—Decreased appetite—Docetaxel—pancreatic cancer	0.00103	0.00127	CcSEcCtD
Desvenlafaxine—Headache—Fluorouracil—pancreatic cancer	0.00102	0.00127	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.00102	0.00127	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00102	0.00127	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.00102	0.00126	CcSEcCtD
Desvenlafaxine—Fatigue—Docetaxel—pancreatic cancer	0.00102	0.00126	CcSEcCtD
Desvenlafaxine—Angiopathy—Epirubicin—pancreatic cancer	0.00102	0.00126	CcSEcCtD
Desvenlafaxine—Urethral disorder—Doxorubicin—pancreatic cancer	0.00102	0.00126	CcSEcCtD
Desvenlafaxine—Nausea—Irinotecan—pancreatic cancer	0.00101	0.00126	CcSEcCtD
Desvenlafaxine—Immune system disorder—Epirubicin—pancreatic cancer	0.00101	0.00126	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.00101	0.00125	CcSEcCtD
Desvenlafaxine—Constipation—Docetaxel—pancreatic cancer	0.00101	0.00125	CcSEcCtD
Desvenlafaxine—Chills—Epirubicin—pancreatic cancer	0.00101	0.00125	CcSEcCtD
Desvenlafaxine—Alopecia—Epirubicin—pancreatic cancer	0.00099	0.00123	CcSEcCtD
Desvenlafaxine—Nausea—Gemcitabine—pancreatic cancer	0.000988	0.00123	CcSEcCtD
Desvenlafaxine—Mental disorder—Epirubicin—pancreatic cancer	0.000981	0.00122	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Doxorubicin—pancreatic cancer	0.00098	0.00122	CcSEcCtD
Desvenlafaxine—Malnutrition—Epirubicin—pancreatic cancer	0.000975	0.00121	CcSEcCtD
Desvenlafaxine—Nausea—Fluorouracil—pancreatic cancer	0.000971	0.00121	CcSEcCtD
Desvenlafaxine—Eye disorder—Doxorubicin—pancreatic cancer	0.000969	0.0012	CcSEcCtD
Desvenlafaxine—Tinnitus—Doxorubicin—pancreatic cancer	0.000966	0.0012	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000962	0.00119	CcSEcCtD
Desvenlafaxine—Tension—Epirubicin—pancreatic cancer	0.000957	0.00119	CcSEcCtD
Desvenlafaxine—Dysgeusia—Epirubicin—pancreatic cancer	0.000955	0.00119	CcSEcCtD
Desvenlafaxine—Nervousness—Epirubicin—pancreatic cancer	0.000947	0.00118	CcSEcCtD
Desvenlafaxine—Angiopathy—Doxorubicin—pancreatic cancer	0.00094	0.00117	CcSEcCtD
Desvenlafaxine—Immune system disorder—Doxorubicin—pancreatic cancer	0.000936	0.00116	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000934	0.00116	CcSEcCtD
Desvenlafaxine—Chills—Doxorubicin—pancreatic cancer	0.00093	0.00115	CcSEcCtD
Desvenlafaxine—Vision blurred—Epirubicin—pancreatic cancer	0.000919	0.00114	CcSEcCtD
Desvenlafaxine—Alopecia—Doxorubicin—pancreatic cancer	0.000916	0.00114	CcSEcCtD
Desvenlafaxine—Mental disorder—Doxorubicin—pancreatic cancer	0.000908	0.00113	CcSEcCtD
Desvenlafaxine—Malnutrition—Doxorubicin—pancreatic cancer	0.000902	0.00112	CcSEcCtD
Desvenlafaxine—Tension—Doxorubicin—pancreatic cancer	0.000885	0.0011	CcSEcCtD
Desvenlafaxine—Dysgeusia—Doxorubicin—pancreatic cancer	0.000884	0.0011	CcSEcCtD
Desvenlafaxine—Nervousness—Doxorubicin—pancreatic cancer	0.000876	0.00109	CcSEcCtD
Desvenlafaxine—Vertigo—Epirubicin—pancreatic cancer	0.000876	0.00109	CcSEcCtD
Desvenlafaxine—Syncope—Epirubicin—pancreatic cancer	0.000874	0.00109	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000869	0.00108	CcSEcCtD
Desvenlafaxine—Palpitations—Epirubicin—pancreatic cancer	0.000862	0.00107	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000857	0.00106	CcSEcCtD
Desvenlafaxine—Vision blurred—Doxorubicin—pancreatic cancer	0.00085	0.00106	CcSEcCtD
Desvenlafaxine—Asthenia—Docetaxel—pancreatic cancer	0.000847	0.00105	CcSEcCtD
Desvenlafaxine—Convulsion—Epirubicin—pancreatic cancer	0.000845	0.00105	CcSEcCtD
Desvenlafaxine—Hypertension—Epirubicin—pancreatic cancer	0.000842	0.00105	CcSEcCtD
Desvenlafaxine—Anxiety—Epirubicin—pancreatic cancer	0.000827	0.00103	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000824	0.00102	CcSEcCtD
Desvenlafaxine—Dry mouth—Epirubicin—pancreatic cancer	0.000812	0.00101	CcSEcCtD
Desvenlafaxine—Vertigo—Doxorubicin—pancreatic cancer	0.000811	0.00101	CcSEcCtD
Desvenlafaxine—Syncope—Doxorubicin—pancreatic cancer	0.000809	0.001	CcSEcCtD
Desvenlafaxine—Diarrhoea—Docetaxel—pancreatic cancer	0.000807	0.001	CcSEcCtD
Desvenlafaxine—Palpitations—Doxorubicin—pancreatic cancer	0.000797	0.00099	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000793	0.000985	CcSEcCtD
Desvenlafaxine—Shock—Epirubicin—pancreatic cancer	0.000783	0.000972	CcSEcCtD
Desvenlafaxine—Convulsion—Doxorubicin—pancreatic cancer	0.000782	0.000971	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Epirubicin—pancreatic cancer	0.00078	0.000969	CcSEcCtD
Desvenlafaxine—Dizziness—Docetaxel—pancreatic cancer	0.00078	0.000969	CcSEcCtD
Desvenlafaxine—Hypertension—Doxorubicin—pancreatic cancer	0.000779	0.000967	CcSEcCtD
Desvenlafaxine—Tachycardia—Epirubicin—pancreatic cancer	0.000777	0.000965	CcSEcCtD
Desvenlafaxine—Skin disorder—Epirubicin—pancreatic cancer	0.000773	0.00096	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000769	0.000955	CcSEcCtD
Desvenlafaxine—Anxiety—Doxorubicin—pancreatic cancer	0.000765	0.000951	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000763	0.000947	CcSEcCtD
Desvenlafaxine—Dry mouth—Doxorubicin—pancreatic cancer	0.000751	0.000933	CcSEcCtD
Desvenlafaxine—Vomiting—Docetaxel—pancreatic cancer	0.00075	0.000932	CcSEcCtD
Desvenlafaxine—Rash—Docetaxel—pancreatic cancer	0.000744	0.000924	CcSEcCtD
Desvenlafaxine—Dermatitis—Docetaxel—pancreatic cancer	0.000743	0.000923	CcSEcCtD
Desvenlafaxine—Headache—Docetaxel—pancreatic cancer	0.000739	0.000918	CcSEcCtD
Desvenlafaxine—Shock—Doxorubicin—pancreatic cancer	0.000724	0.0009	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000722	0.000897	CcSEcCtD
Desvenlafaxine—Insomnia—Epirubicin—pancreatic cancer	0.00072	0.000894	CcSEcCtD
Desvenlafaxine—Tachycardia—Doxorubicin—pancreatic cancer	0.000719	0.000893	CcSEcCtD
Desvenlafaxine—Skin disorder—Doxorubicin—pancreatic cancer	0.000715	0.000888	CcSEcCtD
Desvenlafaxine—Paraesthesia—Epirubicin—pancreatic cancer	0.000715	0.000887	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000712	0.000884	CcSEcCtD
Desvenlafaxine—Somnolence—Epirubicin—pancreatic cancer	0.000707	0.000879	CcSEcCtD
Desvenlafaxine—Nausea—Docetaxel—pancreatic cancer	0.000701	0.00087	CcSEcCtD
Desvenlafaxine—Decreased appetite—Epirubicin—pancreatic cancer	0.000692	0.000859	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000687	0.000853	CcSEcCtD
Desvenlafaxine—Fatigue—Epirubicin—pancreatic cancer	0.000686	0.000852	CcSEcCtD
Desvenlafaxine—Constipation—Epirubicin—pancreatic cancer	0.000681	0.000845	CcSEcCtD
Desvenlafaxine—Insomnia—Doxorubicin—pancreatic cancer	0.000666	0.000827	CcSEcCtD
Desvenlafaxine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000661	0.000821	CcSEcCtD
Desvenlafaxine—Somnolence—Doxorubicin—pancreatic cancer	0.000655	0.000813	CcSEcCtD
Desvenlafaxine—Decreased appetite—Doxorubicin—pancreatic cancer	0.00064	0.000795	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000636	0.00079	CcSEcCtD
Desvenlafaxine—Fatigue—Doxorubicin—pancreatic cancer	0.000635	0.000788	CcSEcCtD
Desvenlafaxine—Constipation—Doxorubicin—pancreatic cancer	0.00063	0.000782	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000586	0.000728	CcSEcCtD
Desvenlafaxine—Asthenia—Epirubicin—pancreatic cancer	0.000571	0.000709	CcSEcCtD
Desvenlafaxine—Diarrhoea—Epirubicin—pancreatic cancer	0.000544	0.000676	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000543	0.000674	CcSEcCtD
Desvenlafaxine—Asthenia—Doxorubicin—pancreatic cancer	0.000528	0.000656	CcSEcCtD
Desvenlafaxine—Dizziness—Epirubicin—pancreatic cancer	0.000526	0.000654	CcSEcCtD
Desvenlafaxine—Vomiting—Epirubicin—pancreatic cancer	0.000506	0.000628	CcSEcCtD
Desvenlafaxine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000504	0.000626	CcSEcCtD
Desvenlafaxine—Rash—Epirubicin—pancreatic cancer	0.000502	0.000623	CcSEcCtD
Desvenlafaxine—Dermatitis—Epirubicin—pancreatic cancer	0.000501	0.000623	CcSEcCtD
Desvenlafaxine—Headache—Epirubicin—pancreatic cancer	0.000499	0.000619	CcSEcCtD
Desvenlafaxine—Dizziness—Doxorubicin—pancreatic cancer	0.000487	0.000605	CcSEcCtD
Desvenlafaxine—Nausea—Epirubicin—pancreatic cancer	0.000473	0.000587	CcSEcCtD
Desvenlafaxine—Vomiting—Doxorubicin—pancreatic cancer	0.000468	0.000581	CcSEcCtD
Desvenlafaxine—Rash—Doxorubicin—pancreatic cancer	0.000464	0.000577	CcSEcCtD
Desvenlafaxine—Dermatitis—Doxorubicin—pancreatic cancer	0.000464	0.000576	CcSEcCtD
Desvenlafaxine—Headache—Doxorubicin—pancreatic cancer	0.000461	0.000573	CcSEcCtD
Desvenlafaxine—Nausea—Doxorubicin—pancreatic cancer	0.000437	0.000543	CcSEcCtD
